Boston Research & Management Inc. boosted its stake in shares of JPMorgan Chase Capital XVI JP Morgan Alerian MLP ETN (NYSEARCA:AMJ) by 4.1% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 36,290 shares of the exchange traded fund’s stock after buying an additional 1,420 shares during the period. Boston Research & Management Inc.’s holdings in JPMorgan Chase Capital XVI JP Morgan Alerian MLP ETN were worth $1,077,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of the stock. Solaris Asset Management LLC boosted its position in JPMorgan Chase Capital XVI JP Morgan Alerian MLP ETN by 1.1% in the second quarter. Solaris Asset Management LLC now owns 3,845 shares of the exchange traded fund’s stock worth $114,000 after buying an additional 40 shares in the last quarter. Insight 2811 Inc. bought a new position in JPMorgan Chase Capital XVI JP Morgan Alerian MLP ETN during the second quarter worth approximately $332,000. Apriem Advisors boosted its position in JPMorgan Chase Capital XVI JP Morgan Alerian MLP ETN by 1.8% in the second quarter. Apriem Advisors now owns 17,995 shares of the exchange traded fund’s stock worth $534,000 after buying an additional 320 shares in the last quarter. Ruggie Capital Group boosted its position in JPMorgan Chase Capital XVI JP Morgan Alerian MLP ETN by 14.5% in the second quarter. Ruggie Capital Group now owns 18,055 shares of the exchange traded fund’s stock worth $536,000 after buying an additional 2,285 shares in the last quarter. Finally, WASHINGTON TRUST Co boosted its position in JPMorgan Chase Capital XVI JP Morgan Alerian MLP ETN by 2.9% in the second quarter. WASHINGTON TRUST Co now owns 20,070 shares of the exchange traded fund’s stock worth $595,000 after buying an additional 568 shares in the last quarter.

JPMorgan Chase Capital XVI JP Morgan Alerian MLP ETN (NYSEARCA AMJ) traded down 0.44% during trading on Wednesday, reaching $27.25. 111,676 shares of the company’s stock were exchanged. JPMorgan Chase Capital XVI JP Morgan Alerian MLP ETN has a 12-month low of $26.99 and a 12-month high of $34.41. The stock’s 50-day moving average is $29.11 and its 200-day moving average is $30.83.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 6th. Investors of record on Monday, August 28th will be paid a $0.483 dividend. This represents a $1.93 annualized dividend and a yield of 7.06%. The ex-dividend date of this dividend is Thursday, August 24th.

TRADEMARK VIOLATION NOTICE: This story was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this story can be accessed at https://www.thecerbatgem.com/2017/08/30/jpmorgan-chase-capital-xvi-jp-morgan-alerian-mlp-etn-amj-position-raised-by-boston-research-management-inc.html.

Want to see what other hedge funds are holding AMJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for JPMorgan Chase Capital XVI JP Morgan Alerian MLP ETN (NYSEARCA:AMJ).

Institutional Ownership by Quarter for JPMorgan Chase Capital XVI JP Morgan Alerian MLP ETN (NYSEARCA:AMJ)

Receive News & Stock Ratings for JPMorgan Chase Capital XVI JP Morgan Alerian MLP ETN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan Chase Capital XVI JP Morgan Alerian MLP ETN and related stocks with our FREE daily email newsletter.